Kevin Appelbaum

Kevin Appelbaum

Founder at Better Therapeutics LLC

Net worth: 33 694 $ as of 31/03/2024

60 year
Health Technology
Consumer Non-Durables
Commercial Services

Profile

Kevin J.
Appelbaum
is the founder of Medley Health, Inc. (2010), Better Therapeutics LLC (2015), and Better Therapeutics, Inc. (2015).
At Medley Health, he was the Chairman.
At Better Therapeutics LLC, he is currently the Chief Executive Officer & Director.
At Better Therapeutics, Inc., he was the President, Chief Executive Officer & Director.
Mr. Appelbaum's current job is as a Director at ConsumerMed.
Org.
He was also a Member at Young Presidents' Organization, Inc. (1999-2002).
Mr. Appelbaum received his undergraduate degree from the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/09/2023 2,406,719 ( 4.43% ) 33 694 $ 31/03/2024

Kevin Appelbaum active positions

CompaniesPositionStart
ConsumerMed.Org Director/Board Member -
Founder 01/04/2015
All active positions of Kevin Appelbaum

Former positions of Kevin Appelbaum

CompaniesPositionEnd
BETTER THERAPEUTICS, INC. Founder 05/07/2022
Chief Executive Officer 28/10/2014
Director/Board Member 30/01/2013
Corporate Officer/Principal -
Corporate Officer/Principal 01/01/2002
See the detail of Kevin Appelbaum's experience

Training of Kevin Appelbaum

University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Appelbaum's experience

Connections

50

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PEPSICO, INC.

Consumer Non-Durables

PROCTER & GAMBLE COMPANY

Consumer Non-Durables

Private companies10

Health Technology

Health Services

Technology Services

Retail Trade

Health Technology

Commercial Services

Commercial Services

ConsumerMed.Org

Health Technology

Better Therapeutics, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Kevin Appelbaum